Markus Loeffler
Impact in
- Genetics top 0.05%
- Glioma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment
- Genetic factors in colorectal cancer
Papers in
-
- Lymphoma Diagnosis and Treatment 85
- Oncology 87
- Cancer Cells and Metastasis 28
- Co-authors
- C.S. Potten (7 shared papers)Michael Pfreundschuh (62 shared papers)Ingo Roeder (17 shared papers)Norbert Schmitz (43 shared papers)Christoph Engel (69 shared papers)Christopher S. Potten (13 shared papers)Marita Ziepert (38 shared papers)Dirk Hasenclever (21 shared papers)
- Journals
- Journal of Clinical Oncology (43 papers)Blood (38 papers)Annals of Oncology (23 papers)Cell Proliferation (22 papers)PLoS ONE (18 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Markus Loeffler
386 papers receiving 18.4k citations
Markus Loeffler's Hit Papers
Peers
Comparison fields: 5 of 199
- Genetics 3.7k
- Pathology and Forensic Medicine 5.1k
- Oncology 4.7k
- Neurology 1.9k
- Cancer Research 1.8k
Countries citing papers authored by Markus Loeffler
This map shows the geographic impact of Markus Loeffler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Loeffler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Loeffler more than expected).
Fields of papers citing papers by Markus Loeffler
This network shows the impact of papers produced by Markus Loeffler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Loeffler. The network helps show where Markus Loeffler may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Loeffler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 395 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt Hit paper breakdown → | 1990 | 1398 |
| 2 | Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas Hit paper breakdown → | 2010 | 631 |
| 3 | Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease Hit paper breakdown → | 2003 | 537 |
| 4 | Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake Hit paper breakdown → | 2006 | 527 |
| 5 | Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network Hit paper breakdown → | 2009 | 478 |
| 6 | Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era Hit paper breakdown → | 2010 | 414 |
| 7 | 2010 | 381 | |
| 8 | MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma Hit paper breakdown → | 2013 | 373 |
| 9 | Predicting brain-age from multimodal imaging data captures cognitive impairment Hit paper breakdown → | 2016 | 311 |
| 10 | 2016 | 269 | |
| 11 | 2006 | 250 | |
| 12 | 2007 | 232 | |
| 13 | 2009 | 220 | |
| 14 | 2011 | 214 | |
| 15 | 2004 | 207 | |
| 16 | 1999 | 204 | |
| 17 | 2006 | 199 | |
| 18 | 2001 | 199 | |
| 19 | 2009 | 197 | |
| 20 | 2011 | 188 |
About Markus Loeffler
Markus Loeffler is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Molecular Biology and Hematology, having authored 395 papers that have together received 18.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (85 papers), Chronic Lymphocytic Leukemia Research (40 papers), Cancer Cells and Metastasis (28 papers), Glioma Diagnosis and Treatment (26 papers), Hematopoietic Stem Cell Transplantation (22 papers), Lung Cancer Treatments and Mutations (18 papers), CNS Lymphoma Diagnosis and Treatment (17 papers) and Erythrocyte Function and Pathophysiology (15 papers). The work is most often cited by research in Genetics (3.7k citations), Pathology and Forensic Medicine (5.1k citations), Oncology (4.7k citations), Neurology (1.9k citations) and Cancer Research (1.8k citations). Markus Loeffler has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include C.S. Potten, Michael Pfreundschuh, Ingo Roeder, Norbert Schmitz, Christoph Engel, Christopher S. Potten, Marita Ziepert, Dirk Hasenclever, Markus Scholz and Volker Diehl. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, Cell Proliferation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.